These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 28994688)

  • 1. The use of intravenous hydroxocobalamin as a rescue in methylene blue-resistant vasoplegic syndrome in cardiac surgery.
    Cai Y; Mack A; Ladlie BL; Martin AK
    Ann Card Anaesth; 2017; 20(4):462-464. PubMed ID: 28994688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of Intravenous Hydroxocobalamin without Methylene Blue for Refractory Vasoplegic Syndrome After Cardiopulmonary Bypass.
    Peyko V; Finamore M
    Am J Case Rep; 2021 Jun; 22():e930890. PubMed ID: 34143764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxocobalamin With or Without Methylene Blue May Improve Fluid Balance in Critically Ill Patients With Vasoplegic Syndrome After Cardiac Surgery: A Report of Two Cases.
    Zundel MT; Feih JT; Rinka JRG; Boettcher BT; Freed JK; Kaiser M; Ghadiali HY; Tawil JN; Woehlck HJ; Pagel PS
    J Cardiothorac Vasc Anesth; 2018 Feb; 32(1):452-457. PubMed ID: 28778773
    [No Abstract]   [Full Text] [Related]  

  • 4. Hydroxocobalamin as a Rescue Treatment for Refractory Vasoplegic Syndrome After Prolonged Cardiopulmonary Bypass.
    Burnes ML; Boettcher BT; Woehlck HJ; Zundel MT; Iqbal Z; Pagel PS
    J Cardiothorac Vasc Anesth; 2017 Jun; 31(3):1012-1014. PubMed ID: 27838199
    [No Abstract]   [Full Text] [Related]  

  • 5. Methylene Blue for Vasoplegic Syndrome.
    Booth AT; Melmer PD; Tribble B; Mehaffey JH; Tribble C
    Heart Surg Forum; 2017 Oct; 20(5):E234-E238. PubMed ID: 29087290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroxocobalamin for Vasoplegic Syndrome in Liver Transplantation: Restoration of Blood Pressure Without Vasospasm.
    Woehlck HJ; Boettcher BT; Lauer KK; Cronin DC; Hong JC; Zimmerman MA; Kim J; Selim M
    A A Case Rep; 2016 Dec; 7(12):247-250. PubMed ID: 27749291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylene Blue Monotherapy Compared With Combination Therapy With Hydroxocobalamin for the Treatment of Refractory Vasoplegic Syndrome: ARetrospective Cohort Study.
    Feih JT; Rinka JRG; Zundel MT
    J Cardiothorac Vasc Anesth; 2019 May; 33(5):1301-1307. PubMed ID: 30606508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasoplegic syndrome after cardiovascular surgery: A review of pathophysiology and outcome-oriented therapeutic management.
    Datt V; Wadhhwa R; Sharma V; Virmani S; Minhas HS; Malik S
    J Card Surg; 2021 Oct; 36(10):3749-3760. PubMed ID: 34251716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylene blue: potential use of an antique molecule in vasoplegic syndrome during cardiac surgery.
    Lenglet S; Mach F; Montecucco F
    Expert Rev Cardiovasc Ther; 2011 Dec; 9(12):1519-25. PubMed ID: 22103871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylene blue is associated with poor outcomes in vasoplegic shock.
    Weiner MM; Lin HM; Danforth D; Rao S; Hosseinian L; Fischer GW
    J Cardiothorac Vasc Anesth; 2013 Dec; 27(6):1233-8. PubMed ID: 23972738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasoplegia During Cardiopulmonary Bypass: Current Literature and Rescue Therapy Options.
    Ortoleva J; Shapeton A; Vanneman M; Dalia AA
    J Cardiothorac Vasc Anesth; 2020 Oct; 34(10):2766-2775. PubMed ID: 31917073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Vasoplegic Syndrome With Intravenous Hydroxocobalamin During Liver Transplantation.
    Boettcher BT; Woehlck HJ; Reck SE; Hong JC; Zimmerman MA; Kim J; Zundel MT; Freed JK; Pagel PS
    J Cardiothorac Vasc Anesth; 2017 Aug; 31(4):1381-1384. PubMed ID: 28012726
    [No Abstract]   [Full Text] [Related]  

  • 13. Vasoplegic Syndrome in Patients Undergoing Cardiac Surgery: A Literature Review.
    Nash CM
    AACN Adv Crit Care; 2021 Jun; 32(2):137-145. PubMed ID: 34161970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxocobalamin or Methylene Blue for Vasoplegic Syndrome in Adult Cardiothoracic Surgery.
    Kram SJ; Kram BL; Cook JC; Ohman KL; Ghadimi K
    J Cardiothorac Vasc Anesth; 2022 Feb; 36(2):469-476. PubMed ID: 34176677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case report of high-dose hydroxocobalamin in the treatment of vasoplegic syndrome during liver transplantation.
    An SS; Henson CP; Freundlich RE; McEvoy MD
    Am J Transplant; 2018 Jun; 18(6):1552-1555. PubMed ID: 29573551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery.
    Levin RL; Degrange MA; Bruno GF; Del Mazo CD; Taborda DJ; Griotti JJ; Boullon FJ
    Ann Thorac Surg; 2004 Feb; 77(2):496-9. PubMed ID: 14759425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasoplegia After Cardiovascular Procedures-Pathophysiology and Targeted Therapy.
    Shaefi S; Mittel A; Klick J; Evans A; Ivascu NS; Gutsche J; Augoustides JGT
    J Cardiothorac Vasc Anesth; 2018 Apr; 32(2):1013-1022. PubMed ID: 29223724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraoperative vasoplegia: methylene blue to the rescue!
    McCartney SL; Duce L; Ghadimi K
    Curr Opin Anaesthesiol; 2018 Feb; 31(1):43-49. PubMed ID: 29176374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Reminder of Methylene Blue's Effectiveness in Treating Vasoplegic Syndrome after On-Pump Cardiac Surgery.
    Manghelli J; Brown L; Tadros HB; Munfakh NA
    Tex Heart Inst J; 2015 Oct; 42(5):491-4. PubMed ID: 26504450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylene Blue for Vasoplegic Syndrome After Cardiac Operation: Early Administration Improves Survival.
    Mehaffey JH; Johnston LE; Hawkins RB; Charles EJ; Yarboro L; Kern JA; Ailawadi G; Kron IL; Ghanta RK
    Ann Thorac Surg; 2017 Jul; 104(1):36-41. PubMed ID: 28551045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.